Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Cardiff Oncology, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.069 -- 00:00:05.132 Welcome to the Cardiff Oncology Second Quarter 2024 Financial Results 00:00:05.132 -- 00:00:10.615 and Business Update Conference Call. At this time, all participants are in a listen-only 00:00:10.615 -- 00:00:16.319 mode. After the speaker's presentation, there will be a question and answer session. 00:00:16.319 -- 00:00:21.742 To ask a question during the session, you will need to press star 1 on your telephone, 00:00:21.742 -- 00:00:26.505 and you will then hear an automated message advising your hand is raised. 00:00:26.505 -- 00:00:30.430 Please be advised that today's conference is being recorded. 00:00:30.430 -- 00:00:36.072 I would now like to turn the conference call over to Kiki Patel of Gale Martin Group. 00:00:36.072 -- 00:00:38.572 Please go ahead. 00:00:40.314 -- 00:00:45.475 Thank you, Operator. Joining us on the call today from Cardiff Oncology are Chief Executive 00:00:45.475 -- 00:00:50.137 Officer Mark Erlander and Chief Financial Officer Jamie Levine. 00:00:50.137 -- 00:00:54.199 During this conference call, management will make forward-looking statements including, 00:00:54.199 -- 00:00:59.123 without limitation, statements related to guidance, results, and the timing of data readouts 00:00:59.123 -- 00:01:01.705 for our advanced research clinical trials. 00:01:01.705 -- 00:01:05.868 These forward-looking statements are based on the company's current expectations and 00:01:05.868 -- 00:01:09.630 inherently involve significant risks and uncertainties. 00:01:09.630 -- 00:01:14.173 Our actual results and the timing of events could differ materially from those anticipated 00:01:14.173 -- 00:01:18.803 in such forward-looking statements as a result of these risks and uncertainties. 00:01:18.803 -- 00:01:22.586 Factor...